EV/EBITDA
-3.79
-1.08-39.85%
Fri, 07 Mar 2025 23:40:50 GMT
Summary
- As of March 10, 2025, BGLC EV/EBITDA is -3.79, with a fall of -1.08 (-39.85%) during the most recent trading day.
- Over the past year, BGLC EV/EBITDA has dropped by -0.65 (-20.70%).
- BGLC EV/EBITDA is now -103.35% below its all-time high of 113.05.
Performance
BGLC EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
BGLC EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -39.9% | +40.1% | +13.8% |
| 1 m1 month | +4.3% | -4.1% | -1.8% |
| 3 m3 months | -121.6% | +121.8% | +30.4% |
| 6 m6 months | -307.5% | +57.8% | -3.0% |
| ytdytd | -531.7% | +530.4% | +55.5% |
| 1 y1 year | -20.7% | -63.1% | -50.9% |
| 5 y5 years | - | - | - |
BGLC EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -73.1% | -3.96 | +4.3% | |
| 3 m | 3-month | -0.14 | -2607.1% | -5.02 | +24.5% |
| 6 m | 6-month | -0.14 | -2607.1% | -5.34 | +29.0% |
| 1 y | 1-year | -0.14 | -2607.1% | -5.34 | +29.0% |
| 3 y | 3-year | 113.05 | -103.3% | -206.21 | +98.2% |
| 5 y | 5-year | 113.05 | -103.3% | -206.21 | +98.2% |
| alltime | all time | 113.05 | -103.3% | -206.21 | +98.2% |
BioNexus Gene Lab EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.79(+531.7%) |
| 2024 | -0.60(-57.1%) |
| Date | Value |
|---|---|
| 2023 | -1.40(-97.8%) |
| 2022 | -62.92(-358.4%) |
| 2021 | 24.35 |
FAQ
- What is BioNexus Gene Lab EV/EBITDA?
- What is the all time high EV/EBITDA for BioNexus Gene Lab?
- What is BGLC EV/EBITDA year-to-date change?
- What is BioNexus Gene Lab EV/EBITDA year-on-year change?
What is BioNexus Gene Lab EV/EBITDA?
The current EV/EBITDA of BGLC is -3.79
What is the all time high EV/EBITDA for BioNexus Gene Lab?
BioNexus Gene Lab all-time high EV/EBITDA is 113.05
What is BGLC EV/EBITDA year-to-date change?
BioNexus Gene Lab EV/EBITDA has changed by -3.19 (-531.67%) since the beginning of the year
What is BioNexus Gene Lab EV/EBITDA year-on-year change?
Over the past year, BGLC EV/EBITDA has changed by -0.65 (-20.70%)